Lactobacillus reuteri in the treatment of Helicobacter pylori infection

Internal and Emergency Medicine

Volumn 9, Issue 6, 2014, Pages 649-654

  Dore, Maria Pina ^a,b   Cuccu, Marianna ^a   Pes, Gianni Mario ^a   Manca, Alessandra ^a   Graham, David Yates ^b  

^a UNIVERSITY OF SASSARI   (Italy)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

H. pylori; Lactobacillus reuteri; Probiotics; Treatment

Indexed keywords

PROBIOTIC AGENT;

ADULT; AGED; CLINICAL TRIAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMAN; LACTOBACILLUS REUTERI; MALE; MIDDLE AGED; PILOT STUDY; PROSPECTIVE STUDY; YOUNG ADULT;

ADULT; AGED; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LACTOBACILLUS REUTERI; MALE; MIDDLE AGED; PILOT PROJECTS; PROBIOTICS; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84909598371     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-013-1013-z     Document Type: Article

References (32)

1. Horiki N, Omata F, Uemura M, Suzuki S, Ishii N, Iizuka Y, Fukuda K, Fujita Y, Katsurahara M, Ito T, Cesar GE, Imoto I, Takei Y (2009) Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan. Helicobacter 14:86–90
2. Megraud F, Coenen S, Versporten A, Kist M, Kist M, Lopez-Brea M, Hirschl AM, Andersen LP, Goossens H, Glupczynski Y, Study Group participants (2013) Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut 62:34–42
3. Gatta L, Vakil N, Vaira D, Scarpignato C (2013) Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy. BMJ 347:f4587
4. Power SE, O’Toole PW, Stanton C, Ross RP, Fitzgerald GF (2013) Intestinal microbiota, diet and health. Br J Nutr 12:1–16 [Epub ahead of print]
5. Schlundt J (2012) “Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria”. Report of a joint FAO/WHO Expert Consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. FAO/WHO. Retrieved 17 December 2012
6. Metchnikoff E (1907) Optimistic studies. In: Chalmers Mitchell P (ed) Essais optimistes. Paris. The prolongation of life. Heinemann, London
7. Macfarlane GT, Cummings JH (2002) Probiotics, infection and immunity. Curr Opin Infect Dis 15:501–506
8. Ritchie ML, Romanuk TN (2012) A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One 7:e34938
9. Malfertheiner P, Megraud F, O’Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ, European Helicobacter Study Group (2012) Management of Helicobacter pylori infection––the Maastricht IV/Florence consensus report. Gut 61:646–664
10. Mukai T, Asasaka T, Sato E, Mori K, Matsumoto M, Ohori H (2002) Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri. FEMS Immunol Med Microbiol 32:105–110
11. Valeur N, Engel P, Carbajal N, Connolly E, Ladefoged K (2004) Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environ Microbiol 70:1176–1181
12. Chung T, Axelsson S (1989) In vitro studies on reuterin synthesis by Lactobacillus reuteri. Microb Ecol Health Dis 2:137–144
13. Höltzel A, Gänzle MG, Nicholson GJ (2000) The first low molecular weight antibiotic from lactic acid bacteria: reutericyclin, a new tetramic acid. Angew Chem Int Ed Engl 39:2766–2768
14. 13C-urea to diagnose Helicobacter pylori infection: a randomised controlled trial. Gut 4:457–462
15. Dore MP, Graham DY, Mele R, Marras L, Nieddu S, Manca A, Realdi G (2002) Colloidal bismuth subcitrate-containing twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection. Am J Gastroenterol 97:857–860
16. Carr FJ, Chill D, Maida N (2002) The lactic acid bacteria: a literature survey. Crit Rev Microbiol 28:281–370
17. Cotter PD, Hill C (2003) Surviving the acid test: responses of gram-positive bacteria to low pH. Microbiol Mol Biol Rev 67:429–453
18. Midolo PD, Lambert JR, Hull R, Luo F, Grayson ML (1995) In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J Appl Bacteriol 79:475–479
19. Lam EK, Tai EK, Koo MW, Wong HP, Wu WK, Yu L, So WH, Woo PC, Cho CH (2007) Enhancement of gastric mucosal integrity by Lactobacillus rhamnosus GG. Life Sci 80:2128–2136
20. Uchida M, Shimizu K, Kurakazu K (2010) Yogurt containing Lactobacillus gasseri OLL 2716 (LG21 yogurt) accelerated the healing of acetic acid-induced gastric ulcer in rats. Biosci Biotechnol Biochem 74:1891–1894
21. Imase K, Tanaka A, Tokunaga K, Sugano H, Ishida H, Takahashi S (2007) Lactobacillus reuteri tablets suppress Helicobacter pylori infection––a double-blind randomised placebo-controlled cross-over clinical study. Kansenshogaku Zasshi 81:387–393
22. Scaccianoce G, Zullo A, Hassan C, Gentili F, Cristofari F, Cardinale V, Gigliotti F, Piglionica D, Morini S (2008) Triple therapies plus different probiotics for Helicobacter pylori eradication. Eur Rev Med Pharmacol Sci 4:251–256
23. Arakawa T, Watanabe T, Kobayashi K (1997) The immunology of H. pylori: from pathogenesis to prevention. In: Ernst PB, Michetti P, Smith PD (eds) Regulation of acid secretion and peptic ulcer formation by inflammatory cytokines. Lippincott-Raven, Philadelphia, pp 183–199
24. Noach LA, Bosma NB, Jansen J (1994) Mucosal tumor necrosis factor alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 29:425–429
25. Gotteland M, Cruchet S, Verbeke S (2001) Effect of Lactobacillus ingestion on the gastrointestinal mucosal barrier alterations induced by indometacin in humans. Aliment Pharmacol Ther 15:11–17
26. Vandenbergh PA (1993) Lactic acid bacteria, their metabolic products and interference with microbial growth. FEMS Microbiol Rev 12:221–238
27. Felley CP, Corthe′sy-Theulaz I, Rivero J-LB, Sipponen P, Kaufmann M, Bauerfeind P, Wiesel PH, Brassart D, Pfeifer A, Blum AL, Michetti P (2001) Favourable effects of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. Eur J Gastroenterol Hepatol 13:25–29
28. Michetti P, Dorta G, Wiesel PH, Brassart D, Verdu E, Herranz M, Felley C, Porta N, Rouvet M, Blum AL, Corthésy-Theulaz I (1999) Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in human. Digestion 60:203–209
29. Sakamoto I, Igarashi M, Kimura K, Takagi A, Miwa T, Koga Y (2001) Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J Antimicrob Chemother 47:709–710
30. Wang ZH, Gao QY, Fang JY (2013) Meta-analysis of the efficacy and safety of Lactobacillus-containing and Bifidobacterium-containing probiotic compound preparation in Helicobacter pylori eradication therapy. J Clin Gastroenterol 47:25–32
31. Armuzzi A, Cremonini F, Bartolozzi F, Bartolozzi F, Canducci F, Candelli M, Santarelli L, Cammarota G, De Lorenzo A, Pola P, Gasbarrini G, Gasbarrini A (2001) The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 15:163–169
32. Saggioro A, Caron M, Pasini M, Bortoluzzi F, Girardi L, Pilone G (2005) Helicobacter pylori eradication with Lactobacillus reuteri. A double-blind-placebo-controlled study. Dig Liver Dis 37(Supp1):S88 [Abstract] P01.49